Bioequivalence and Bioavailability Forum 13:47 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Potvin C or B? [Two-Stage / GS Designs]

posted by Helmut Homepage - Vienna, Austria, 2012-06-02 18:54  - Posting: # 8656
Views: 8,312

Gossip:

One regulator (I leave it to your imagination which one of EMA’s working parties he belongs to) told me that

Our [i.e., his agency’s] statisticians don’t believe* that in Potvin’s Method C the patient’s risk is preserved at ~5%. They suggest to use only Method B because application of Pocock’s α 0.0294 is well known.

I suggested to tell them to have a closer look at the empiric alphas (the endless tables in the paper). BTW, specifically Method C (not B!) is recommended by the FDA and in the recent Canadian GL.



Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,782 posts in 4,002 threads, 1,257 registered users;
online 8 (1 registered, 7 guests [including 4 identified bots]).

Power Calculation – A guess masquerading
as mathematics.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed